Patients’ information and perspectives on biosimilars in rheumatology: a French nation-wide survey

Conclusion : Biosimilars are largely unknown to patients. Information seems to be instrumental in improving the patients’ adherence to biosimilars and could help preserving the therapeutic relationship and avoiding a nocebo effect.
Source: Joint Bone Spine - Category: Orthopaedics Source Type: research